82.62  0.05 (0.06%)		12-26 16:00
Open: 82.7 High: 82.88 Volume: 1,212,074		Pre. Close: 82.57 Low: 81.96 Market Cap: 16,450(M)

Short term
Mid term
Targets	6-month :	104.92	1-year :	122.54
Resists	First :	89.83	Second :	104.92
Pivot price	81.67
Supports	First :	78.19	Second :	71.01
MAs	MA(5) :	82.93	MA(20) :	80.46
	MA(100) :	72.51	MA(250) :	0
MACD	MACD :	2.3	Signal :	2.3
%K %D	K(14,3) :	47	D(3) :	51.4
RSI	RSI(14): 63.8
52-week	High :	100.23	Low :	61.77

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ COO ] has closed below upper band by 34.5%. Bollinger Bands are 25.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	82.92 - 83.33	83.33 - 83.74
Low:	80.99 - 81.42	81.42 - 81.85
Close:	81.93 - 82.61	82.61 - 83.3

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Fri, 26 Dec 2025
Assenagon Asset Management S.A. Reduces Stock Position in The Cooper Companies, Inc. $COO - MarketBeat

Thu, 25 Dec 2025
The Cooper Companies, Inc. (NASDAQ:COO) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Wed, 24 Dec 2025
Albert White Bought 4.4% More Shares In Cooper Companies - simplywall.st

Wed, 24 Dec 2025
CooperCompanies Appoints Walter M. Rosebrough, Jr. to its Board of Directors - VisionMonday.com

Tue, 23 Dec 2025
The Cooper Companies, Inc. Appoints Walter M Rosebrough, Jr. to Its Board of Directors and Corporate Governance & Nominating Committee and Appoints as Chair of the Board, Effective as of January 3, 2026 - marketscreener.com

Tue, 23 Dec 2025
CooperCompanies Appoints Walt Rosebrough as Independent Director and Enters Cooperation Agreement with Browning West - Quiver Quantitative

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Shares Out	196 (M)
Shares Float	195 (M)
Held by Insiders	0.6 (%)
Held by Institutions	107 (%)
Shares Short	8,010 (K)
Shares Short P.Month	6,450 (K)

EPS	1.87
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	42.06
Profit Margin	9.1 %
Operating Margin	13.5 %
Return on Assets (ttm)	3.4 %
Return on Equity (ttm)	4.5 %
Qtrly Rev. Growth	4.5 %
Gross Profit (p.s.)	13.67
Sales Per Share	20.86
EBITDA (p.s.)	5.4
Qtrly Earnings Growth	-28.3 %
Operating Cash Flow	796 (M)
Levered Free Cash Flow	377 (M)

PE Ratio	44.18
PEG Ratio	0
Price to Book value	1.96
Price to Sales	3.95
Price to Cash Flow	20.33

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.